Mar 23, 2023
Pfizer Japan Starts Commercial Rollout of COVID-19 Pill Paxlovid
Pfizer Japan began the commercial rollout of its oral COVID-19 treatment Paxlovid (nirmatrelvir/ritonavir) on March 22, making it available under the normal wholesaler distribution channel in the country.
Read More
Mar 23, 2023
Vaccination, Paxlovid decrease risk of long Covid, studies show
People who are vaccinated or who take Paxlovid during a Covid-19 infection have a lower risk of developing long Covid, new research shows.
Read More
Mar 23, 2023
Higher Paxlovid uptake in winter 2022 could have prevented nearly 5,000 deaths
In a recent study published in the JAMA Health Forum, researchers in the United States estimated the reduction in coronavirus disease 2019 (COVID-19) mortality rates after the Paxlovid rollout.
Read More